about
Myomectomy at time of cesarean delivery: a retrospective cohort studyIntravaginal misoprostol versus Foley catheter for labour induction: a meta-analysis.Ultrasound in multiple gestations: twins and other multifetal pregnancies.Combined sonographic and endoscopic umbilical cord occlusion in twin and triplet gestations.Maternal and neonatal outcomes after delayed-interval delivery of multifetal pregnancies.Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery in triplet gestations.Factors affecting fetal presentation in twin pregnancies across gestation.Prehypertension in Early Pregnancy: What is the Significance?Uterocervical angle: a novel ultrasound screening tool to predict spontaneous preterm birth.The effect of maternal obesity on pregnancy outcomes of women with gestational diabetes controlled with diet only, glyburide, or insulin.Routine cervical length and fetal fibronectin screening in asymptomatic twin pregnancies: is there clinical benefit?Twin pregnancy in patients with a uterine anomaly.Elevated first trimester PAPP--a is associated with increased risk of placenta accreta.Natural history of vasa previa across gestation using a screening protocol.Blood pressure changes across gestation in patients with twin pregnancies.Prophylactic cerclage in the management of triplet pregnancies.Type of congenital uterine anomaly and adverse pregnancy outcomes.Risk factors for preeclampsia in twin pregnancies.Ultrasound-indicated cerclage: Shirodkar vs. McDonald.The closure of iatrogenic membrane defects after amniocentesis and endoscopic intrauterine procedures.Induction of labor in twin compared with singleton pregnancies.Endoscopic closure of fetal membrane defects: comparing iatrogenic versus spontaneous rupture cases.17-α hydroxyprogesterone caproate for the prevention of preterm birth.The effectiveness of antepartum surveillance in reducing the risk of stillbirth in patients with advanced maternal age.Prophylactic cerclage in the management of twin pregnancies.Cervical length at 30-32 weeks and the risk of Cesarean delivery in twin pregnancies.Prehypertension in early versus late pregnancy.Biochemical screening for aneuploidy in patients with donor oocyte pregnancies compared with autologous pregnancies.Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery after multifetal pregnancy reduction.Second-trimester estimated fetal weight and discordance in twin pregnancies: association with fetal growth restriction.Vaginal fetal fibronectin as a predictor of spontaneous preterm delivery in the patient with cervical cerclage.Weight gain in twin pregnancies and adverse outcomes: examining the 2009 Institute of Medicine guidelines.The effect of maternal obesity on pregnancy outcomes in women with gestational diabetes.First-trimester diagnosis of sacrococcygeal teratoma: the role of three-dimensional ultrasound.Beta 2 adrenergic agents and autism.First-trimester aneuploidy risk assessment: the impact of comprehensive counseling and same-day results on patient satisfaction, anxiety, and knowledge.A national survey examining obstetrician perspectives on use of 17-alpha hydroxyprogesterone caproate post-US FDA approval.Maternal anxiety and ultrasound markers for aneuploidy in a multiethnic population.Two cases of maternal alloimmunization against human neutrophil alloantigen-4b, one causing severe alloimmune neonatal neutropenia.The efficacy of sonographically indicated cerclage in multiple gestations.
P50
Q24794778-25176DF0-30DD-4C37-BB8F-A367EC84358AQ33824025-5EFC056B-39CA-4B2F-8F61-A22A8E7684FFQ36143118-A9BC4B93-28D1-4157-B4DF-B5E429DB06FCQ36327226-9D90537D-9AA3-4360-BD15-8851B2409366Q37770465-1A04E957-C570-4430-A4C9-1C7E7B7C834FQ38001472-FF3521F7-C3EA-4CF5-BF06-CA6C6B62C9A3Q38098577-CC40D6C8-5261-449C-AA00-2A67F637A34CQ39670468-B666DC3A-E7AA-47B1-8BC0-D00624E3ED64Q39886356-5609D2F6-9CA8-45CB-83C4-048740F079D5Q43423691-FF3C92EB-8FA7-4E48-9FE3-C57D39BDD324Q43426753-EB38359A-CB1E-4289-B4AA-325B7032A010Q43505356-78A47337-56B7-43A3-8751-DBC7CA1A5070Q43738398-8C7BFDC0-7106-4F91-AF03-F513A55C5386Q43774343-85ADE1A5-0E25-4F0F-8933-8AAA8F41B20EQ43975493-B636C117-2C5F-405E-9FCA-D0ADD0FE540CQ44085629-B5CFFBC1-34D8-4ACC-8BF6-D00BA6C4CD68Q44099083-4245BA69-9A07-473E-9019-7710EC70A50FQ44656649-CB949588-967D-4EBE-88BD-BC3089DF9084Q44697779-A85D067C-1573-440A-84DB-17114BDBB2DEQ44832445-D7B6FCEC-0EA0-4FF6-A043-075CF9F10958Q45077525-5C8D003D-8882-4769-9D3E-E96528F38876Q45182160-4E46CD4D-ABC0-4AFE-8DCB-CB10C9050C3CQ45250255-50D27141-A214-455E-A7DA-602389D55884Q45754245-B16019DD-8F87-4C0B-8DBB-F41F9343ACC3Q45829868-52A53E8D-4036-426D-A55C-2EDAAF5D3AB6Q45832226-9F2D24F9-F036-46E2-9F9C-58F80C9E7FDBQ46302857-E335167F-399E-47F6-A970-7FC636E4EA68Q46537104-6E9AB5EF-6F90-4F59-A8E9-216B2831F3D5Q47234649-9AA35BF1-E3B9-4A0A-AF49-DF7F21D8150FQ47363930-8B21F153-2BB0-4875-8A50-835F9B30FC6AQ47367934-1AAB146F-5626-4002-AEA2-18F0790C0B9CQ47427413-A3A276B8-D1A3-4648-B794-EB43762FE531Q47839245-DD208F62-860A-42EB-BC63-7A425488F910Q49307892-730BACB7-99BD-4EFC-8307-96B7BCCD4ECFQ50302540-2692EA4C-366F-4DFF-8405-02887579ABAFQ50682248-716192F2-AF7A-4743-A6D6-3CB50FF959DEQ50799671-B921B849-EB14-4A4F-8E1E-D7AFAD96D0EBQ50916489-853C6BCD-8D37-411B-851D-91CA941C3429Q50989287-F53208C0-7237-4DDC-AB67-42BB137E8F3EQ53921835-1C1D94B1-18BA-49C9-94C2-191939B2E132
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ashley S Roman
@ast
Ashley S Roman
@en
Ashley S Roman
@es
Ashley S Roman
@nl
type
label
Ashley S Roman
@ast
Ashley S Roman
@en
Ashley S Roman
@es
Ashley S Roman
@nl
prefLabel
Ashley S Roman
@ast
Ashley S Roman
@en
Ashley S Roman
@es
Ashley S Roman
@nl
P106
P21
P31
P496
0000-0001-5318-6038